PDF-APACITABINE
S
Winter 2018 19
DNA Damage Response DDR Program
C
linical Trial
in Breast Cancer
Sapacitabine PARP inhibitor
Investigators from the Department of Breast Cancer
Download Presentation
"APACITABINE" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.